{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:21:16Z","timestamp":1784647276726,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010816","name":"Anhui Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["202007d07050007"],"award-info":[{"award-number":["202007d07050007"]}],"id":[{"id":"10.13039\/501100010816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Osteoarthritis (OA) is a degenerative joint disease. Excessive nitric oxide (NO) mediates the chondrocyte inflammatory response, apoptosis, and extracellular matrix (ECM) degradation during the occurrence and development of OA. NO in chondrocytes is mainly produced by inducible nitric oxide synthase (iNOS). The aim of this study was to design and synthesize an iNOS dimerization inhibitor and evaluate its effects on chondrocyte inflammation and articular cartilage injury in OA via <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments.<\/jats:p><jats:p><jats:bold>Design:<\/jats:bold> The title compound 22o was designed, synthesized, and screened based on a previous study. The effects of different concentrations (5, 10, and 20\u00a0\u03bcM) of compound 22o on chondrocyte inflammatory response and ECM anabolism or catabolism were evaluated by Western blot and real-time quantitative reverse transcription-polymerase chain reaction using the rat chondrocyte model of IL-1\u03b2-induced OA. Furthermore, different doses (40 and 80\u00a0mg\/kg) of compound 22o were administered by gavage to a rat OA model induced by anterior cruciate ligament transection (ACLT), and their protective effects on the articular cartilage were evaluated by histopathology and immunohistochemistry.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Compound 22o showed effective iNOS inhibitory activity by inhibiting the dimerization of iNOS. It inhibited the IL-1\u03b2-induced expression of cyclooxygenase-2 (COX-2) and matrix metalloproteinase 3 (MMP3) in the chondrocytes, decreased NO production, and significantly increased the expression levels of the ECM anabolic markers, aggrecan (ACAN), and collagen type II (COL2A1). Gavage with compound 22o was found to be effective in the rat OA model induced by ACLT, wherein it regulated the anabolism and catabolism and exerted a protective effect on the articular cartilage.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Compound 22o inhibited the inflammatory response and catabolism of the chondrocytes and reduced articular cartilage injury in the rat OA model, indicating its potential as a disease-modifying OA drug.<\/jats:p>","DOI":"10.3389\/fphar.2022.861183","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:48:27Z","timestamp":1657867707000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["An Inducible Nitric Oxide Synthase Dimerization Inhibitor Prevents the Progression of Osteoarthritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Shang","family":"Xian Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yan Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"De Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Ya Kun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Hui Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhong Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hao Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Ji Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wen Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1002\/jcp.29607","article-title":"Role of iNOS in Osteoarthritis: Pathological and Therapeutic Aspects","volume":"235","author":"Ahmad","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/jcb.24096","article-title":"Inhibition of Inducible Nitric Oxide Synthase Prevents Lipid Peroxidation in Osteoarthritic Chondrocytes","volume":"113","author":"Bentz","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-60761-869-0_24","article-title":"Regulation of Lymphocytes by Nitric Oxide","volume":"677","author":"Bogdan","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory Responses and Inflammation-Associated Diseases in Organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113174","DOI":"10.1016\/j.ejmech.2021.113174","article-title":"Discovery and Development of Novel Pyrimidine and Pyrazolo\/Thieno-Fused Pyrimidine Derivatives as Potent and Orally Active Inducible Nitric Oxide Synthase Dimerization Inhibitor with Efficacy for Arthritis","volume":"213","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.joca.2010.10.019","article-title":"Selenomethionine Inhibits IL-1\u03b2 Inducible Nitric Oxide Synthase (iNOS) and Cyclooxygenase 2 (COX2) Expression in Primary Human Chondrocytes","volume":"19","author":"Cheng","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"B7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible Nitric Oxide Synthase: Regulation, Structure, and Inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0140-6736(97)07226-7","article-title":"Osteoarthritis","volume":"350","author":"Creamer","year":"1997","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/annrheumdis-2020-219181","article-title":"Long-Term Structural and Symptomatic Effects of Intra-Articular Sprifermin in Patients with Knee Osteoarthritis: 5-Year Results from the FORWARD Study","volume":"80","author":"Eckstein","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101550","DOI":"10.1016\/j.redox.2020.101550","article-title":"Nitric Oxide in Cellular Adaptation and Disease","volume":"34","author":"Gantner","year":"2020","journal-title":"Redox Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: a Systematic Analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/AJP.0b013e31815e5418","article-title":"Modulation of Pain in Osteoarthritis: The Role of Nitric Oxide","volume":"24","author":"Hancock","year":"2008","journal-title":"Clin. J. Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/humc.2017.249","article-title":"A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients","volume":"29","author":"Kim","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbadis.2016.01.003","article-title":"ROS\/Oxidative Stress Signaling in Osteoarthritis","volume":"1862","author":"Lepetsos","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41401-021-00646-z","article-title":"Methylene Blue Prevents Osteoarthritis Progression and Relieves Pain in Rats via Upregulation of Nrf2\/PRDX1","volume":"43","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"B19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1515\/revneuro-2014-0041","article-title":"Nitric Oxide Synthase in Hypoxic or Ischemic Brain Injury","volume":"26","author":"Liu","year":"2015","journal-title":"Rev. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/ard.2004.022152","article-title":"Effect of Nitric Oxide on Mitochondrial Respiratory Activity of Human Articular Chondrocytes","volume":"64","author":"Maneiro","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/med.21636","article-title":"Inducible Nitric Oxide Synthase Inhibitors: A Comprehensive Update","volume":"40","author":"Minhas","year":"2020","journal-title":"Med. Res. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.pbb.2012.12.013","article-title":"Effect of iNOS Inhibitor S-Methylisothiourea in Monosodium Iodoacetate-Induced Osteoathritic Pain: Implication for Osteoarthritis Therapy","volume":"103","author":"More","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.joca.2020.10.007","article-title":"Osteoarthritis Year in Review 2020: Epidemiology & Therapy","volume":"29","author":"Peat","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R","article-title":"Selective Inhibition of Inducible Nitric Oxide Synthase Reduces Progression of Experimental Osteoarthritis In Vivo: Possible Link with the Reduction in Chondrocyte Apoptosis and Caspase 3 Level","volume":"43","author":"Pelletier","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B25","doi-asserted-by":"publisher","first-page":"G1281","DOI":"10.1152\/ajpgi.00357.2007","article-title":"eNOS Involved in Colitis-Induced Mucosal Blood Flow Increase","volume":"293","author":"Petersson","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-Grade Inflammation as a Key Mediator of the Pathogenesis of Osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/oxfordjournals.jbchem.a021955","article-title":"Nitric Oxide Mediates Interleukin-1-Induced Gene Expression of Matrix Metalloproteinases and Basic Fibroblast Growth Factor in Cultured Rabbit Articular Chondrocytes","volume":"123","author":"Sasaki","year":"1998","journal-title":"J. Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of Nitric Oxide in Inflammatory Diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/s41467-019-09839-x","article-title":"A Small Molecule Promotes Cartilage Extracellular Matrix Generation and Inhibits Osteoarthritis Development","volume":"10","author":"Shi","year":"2019","journal-title":"Nat. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1006\/bbrc.1994.1426","article-title":"Nitric Oxide Mediates Suppression of Cartilage Proteoglycan Synthesis by Interleukin-1","volume":"200","author":"Taskiran","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physrev.00036.2017","article-title":"Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation","volume":"99","author":"Tejero","year":"2019","journal-title":"Physiol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/jcb.21268","article-title":"Nitric Oxide from Both Exogenous and Endogenous Sources Activates Mitochondria-Dependent Events and Induces Insults to Human Chondrocytes","volume":"101","author":"Wu","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/art.41315","article-title":"Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial","volume":"72","author":"Yazici","year":"2020","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.861183\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:48:30Z","timestamp":1657867710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.861183\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":33,"alternative-id":["10.3389\/fphar.2022.861183"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.861183","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"861183"}}